Travere Therapeutics Stock Forecast

Buy or Hold candidate since Jul 08, 2025 Gain 131.63%

The Travere Therapeutics, Inc. stock price gained 2.72% on the last trading day (Monday, 17th Nov 2025), rising from $34.50 to $35.44. During the last trading day the stock fluctuated 3.71% from a day low at $34.54 to a day high of $35.82. The price has been going up and down for this period, and there has been a 2.64% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 164 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $48.99 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 89.09% during the next 3 months and, with a 90% probability hold a price between $61.07 and $70.52 at the end of this 3-month period.

TVTX Signals & Forecast

The Travere Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $34.73 and $29.52. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, November 12, 2025, and so far it has fallen -2.82%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Travere Therapeutics, Inc. stock

Travere Therapeutics, Inc. finds support from accumulated volume at $35.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.28 between high and low, or 3.71%. For the last week, the stock has had daily average volatility of 6.20%.

Our recommended stop-loss: $33.80 (-4.64%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (TVTX) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Travere Therapeutics, Inc. to open at $35.27, and during the day (based on 14 day Average True Range), to move between $34.54 and $36.34, which gives a possible trading interval of +/-$1.80 (+/-5.21%) up or down from last closing price. If Travere Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 5.21% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $35.16 (0.79%) than the resistance at $36.11 (1.89%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Travere Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Travere Therapeutics, Inc. stock to perform well in the short-term.

Current score: 4.433 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $35.27 ( 0.489%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk